Editor LSA

Stocks in the News: Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), American Realty Capital Properties Inc (NASDAQ:ARCP), Dynavax Technologies Corporation (NASDAQ:DVAX), RF Micro Devices, Inc. (NASDAQ:RFMD)

 
Repost This

Lewes, DE -- (SBWIRE) -- 11/13/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), American Realty Capital Properties Inc (NASDAQ:ARCP), Dynavax Technologies Corporation (NASDAQ:DVAX), RF Micro Devices, Inc. (NASDAQ:RFMD)

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) opened its shares at the price of $2.52 for the day. Its closing price was $2.79 after gaining +11.60% for the day. The company traded with the total volume of 4.41 million shares, while its average trading volume remained 3.14 million shares. The beta of ACHN stands at0.54. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection.

Why Should Investors Buy ACHN After The Recent Gain? Just Go Here and Find Out

American Realty Capital Properties Inc (NASDAQ:ARCP) percentage change surged +0.94% to close at $12.88 with the total traded volume of 4.09 million shares, and average volume of 6.73 million. The 52 week range of the stock remained $11.64 - $18.05, while its day lowest price was $12.70 and it hit its day highest price at $12.91. American Realty Capital Properties, Inc. owns and acquires single tenant, freestanding commercial real estate that is net leased on a medium-term basis, primarily to investment grade credit rated and other creditworthy tenants.

For How Long ARCP will Fight for Profitability? Read This Trend Analysis report

Dynavax Technologies Corporation (NASDAQ:DVAX) started its trading session with the price of $1.22 and closed at $1.27 by scoring +4.96%. DVAX’s stocks traded with total volume of 4.02 million shares, while the average trading volume remained 3.01million shares. The beta of DVAX stands at 2.73. Day range of the stock was $1.21 -$1.27. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases.

For How Long DVAX’s Gloss will Attract Investors? Find out via this report

RF Micro Devices, Inc. (NASDAQ:RFMD) ended its day with the gain of +1.80% and closed at the price of $5.10 after opening at $4.99. Stock traded during its last trading session with the total volume of 3.85 million shares, as compared to its average volume of 6.02 million shares. RF Micro Devices, Inc. engages in the design, development, manufacture, and marketing of radio frequency (RF) solutions for original equipment manufacturers and original design manufacturers in wireless.

Will RFMD Continue To Move Higher? Find Out Here

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/